Clinical Trial Update: Metformin in Alzheimer's Dementia Prevention [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial updating on metformin for prevention of Alzheimer’s dementia in individuals with mild cognitive impairment, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Columbia University | Conditions: Mild Cognitive Impairment | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING